Predictors of survival end points in patients with cancer of the cervix on long-term follow-up: Inferences and implications from an audit of patients treated with a specific radiotherapy protocol

Clinical Oncology

Volumn 16, Issue 8, 2004, Pages 536-542

  Datta, N R ^a   Pasricha, R ^a   Singh, U ^a   Srivastava, A ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cancer cervix; External radiotherapy; Intracavitary brachytherapy; Predictors; Survival end points

Indexed keywords

CISPLATIN DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL AUDIT; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; SURVIVAL TIME; UTERINE CERVIX CANCER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DATABASES, FACTUAL; DOSE FRACTIONATION; ENDPOINT DETERMINATION; FEMALE; HUMANS; MEDICAL AUDIT; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 8744293654     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.06.005     Document Type: Article

References (36)

1. Morris M. Eifel P.J. Lu J. et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137-1143
2. Peters W.A.III Liu P.Y. Barrett R.J.II et al. Concurrent chemotherapy and pelvic radiation therapy compared with radiotherapy alone as adjuvant therapy after radical surgery in high-risk early stage-cancer of the cervix J Clin Oncol 18 2000 1606-1613
3. Rose P.G. Bundy B.N. Watkins E.B. et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144-1153
4. Whitney C.W. Sause W. Bundy B.N. et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339-1348
5. Keys H.M. Bundy B.N. Stehman F.B. et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154-1161
6. National Cancer Institute Clinical announcement: Concurrent chemoradiation for cervical cancer February 1999 Department of Public Health Washington, DC
7. Green J.A. Kirwan J.M. Tierney J.F. et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis Lancet 358 2001 781-786
8. Lukka H. Hirte H. Fyles A. et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer-a meta-analysis Clin Oncol 14 2002 203-212
9. Pearcey R. Brundage M. Drouin P. et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix J Clin Oncol 20 2002 966-972
10. Brenna S.M. Zeferino L.C. Pinto G.A. et al. p53 expression as a predictor of recurrence in cervical squamous cell carcinoma Int J Gynecol Cancer 12 2002 299-303
11. Takeda M. Sakuragi N. Okamoto K. et al. Preoperative serum SCC, CA 125 and CA 19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix Acta Obstet Gynecol Scand 81 2002 451-457
12. Graflund M. Sorbe B. Bryne M. Karlsson M. The prognostic value of a histological grading system, DNA profile, and MIB-1 expression in early stages of cervical squamous cell carcinomas Int J Gynecol Cancer 12 2002 149-157
13. Brenna S.M. Zeferino L.C. Pinto G.A. et al. c-Myc protein expression is not an independent predictor in cervical squamous cell carcinoma Braz J Med Biol Res 35 2002 425-430
14. West C.M. Davidson S.E. Roberts S.A. Hunter R.D. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix Br J Cancer 76 1997 1184-1190
15. Dattoli M.J. Gretz H.F.III Beller U. et al. Analysis of multiple prognostic factors in patients with stage IB cervical cancer; age as a major determinant Int J Radiat Oncol Biol Phys 17 1989 41-47
16. Delaloye J.F. Pampallona S. Coucke P.A. De Grandi P. Younger age as a bad prognostic factor in patients with carcinoma of the cervix Eur J Obstet Gynecol Reprod Biol 64 1996 201-205
17. Hirst D.G. Anemia: A problem or an opportunity in radiotherapy? Int J Radiat Oncol Biol Phys 12 1986 2009-2017
18. Toita T. Nakano M. Higashi M. Sakumoto K. Kanazawa K. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy Int J Radiat Oncol Biol Phys 33 1995 843-849
19. Kapp K.S. Stuecklschweiger G.F. Kapp D.S. et al. Prognostic factors in patients of carcinoma of the uterine cervix treated with external beam irradiation and Ir-192 high-dose rate brachytherapy Int J Radiat Oncol Biol Phys 42 1998 531-540
20. Chatani M. Matayoshi Y. Masaki N. Inoue T. High dose intracavitary irradiation for carcinoma of the uterine cervix; the adverse effect of treatment prolongation Strahlenther Onkol 173 1997 379-384
21. Das K.R. Shanta A. Kulkarni R.N. Shah P.K. Ralstron 20B: A high dose rate remote controlled afterloader for brachytherapy Endocurie Hyperthermia Oncol 3 1987 81-89
22. Hong J.H. Chen M.S. Lin F. Tang S.G. Prognostic assessment of tumor regression after external irradiation for cervical cancer Int J Radiat Oncol Biol Phys 22 1992 913-917
23. Kaplan E.S. Meier P.J. Non-parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457-481
24. Cox D.R. Regression models and life tables J R Stat Soc B 34 1972 187-202
25. Waggoner S.E. Cervical cancer Lancet 361 2003 2217-2225
26. Rose P.G. Chemoradiotherapy for cervical cancer Eur J Cancer 38 2002 270-278
27. Maduro J.H. Pras E. Willemse P.H.B. de Vries E.G.E. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer Cancer Treat Rev 29 2003 471-488
28. Grau C. Agarwal J.P. Jabeen K. et al. Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: Results of the IAEA multicentre randomised trial Radiother Oncol 67 2003 17-26
29. Annual Report on the Results of Treatment in Gynecological Cancer J Epidemiol Stat 3 1998 5-34
30. Chen S.W. Liang J.A. Yang S.N. Ko H.L. Lin F.J. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy Radiother Oncol 67 2003 69-76
31. Karolewski K. Korzeniowski S. Sokolowski A. Urbanski K. Kojs Z. Prognostic significance of pretherapeutic and therapeutic factors in patients with advanced cancer of the uterine cervix treated with radical radiotherapy alone Acta Oncol 38 1999 461-468
32. Takeshi K. Katsuyuki K. Yoshiaki T. et al. Definitive radiotherapy combined with high-dose-rate brachytherapy for stage III carcinoma of uterine cervix: Retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters Int J Radiat Oncol Biol Phys 41 1998 319-327
33. Orton C.G. Seyedsadr M. Somnay A. Comparison of high and low dose-rate remote afterloading for cervix cancer and the importance of fractionation Int J Radiat Oncol Biol Phys 21 1991 1425-1434
34. Fyles A. Keane T.J. Barton M. Simm J. The effect of treatment duration in the local control of cervix cancer Radiother Oncol 25 1992 273-279
35. Kapp D.S. Giaccia A.J. New directions for radiation biology research in cancer of the uterine cervix J Natl Cancer Inst Monogr 21 1996 131-139
36. Peters L. McKay M. Predictive assays: Will they ever have a role in the clinic? Int J Radiat Oncol Biol Phys 49 2001 504-510